Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Lancet. Infectious Diseases (Print)

• Publication date

  2009-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1473-3099(09)70227-0PMID 19778766
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure.

  2009cited by this paper
• Mortality and Virologic Outcomes After Access to Antiretroviral Therapy Among a Cohort of HIV-Infected Women Who Received Single-Dose Nevirapine in Lusaka, Zambia

  2009cited by this paper
• Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy.

  2008cited by this paper
• Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared

  2008cited by this paper
• Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004

  2008cited by this paper
• Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.

  2008cited by this paper
• Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project.

  2008cited by this paper
• HIV Drug Resistance Pattern Among HAART-Exposed Patients With Suboptimal Virological Response in Ouagadougou, Burkina Faso

  2008cited by this paper
• Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.

  2008cited by this paper
• Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières

  2008cited by this paper
• Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine.

  2008cited by this paper
• Summary TOWARDS UNIVERSAL ACCESS : Scaling up Priority HIV / AIDS Interventions in the Health Sector Progress Report

  2008cited by this paper
• Initiating Rather than Deferring Haart at a CD4+ Count Between 351-500 Cells/mm 3 is Associated with Improved Survival

  2008cited by this paper
• Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea.

  2008cited by this paper
• Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

  2008cited by this paper
• Immunological response to boosted PI-containing second line ART after switching for clinical/immunological criteria is comparable to response to first-line in patients with low CD4 counts in Africa.

  2008cited by this paper
• Subconjunctival Bevacizumab for Corneal Neovascularization in Herpetic Stromal Keratitis

  2008cited by this paper
• Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania

  2008cited by this paper
• Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up.

  2008cited by this paper
• Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

  2008cited by this paper
• Tolerability and Effectiveness of First-Line Regimens Combining Nevirapine and Lamivudine Plus Zidovudine or Stavudine in Cameroon

  2008cited by this paper
• Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006

  2008cited by this paper
• Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

  2008cited by this paper
• Initiation of Antiretroviral Therapy at CD4 Cell Counts ≥350 Cells/mm3 Does Not Increase Incidence or Risk of Peripheral Neuropathy, Anemia, or Renal Insufficiency

  2008cited by this paper
• Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi

  2007cited by this paper
• Utilization of antiretroviral treatment in Ethiopia between February and December 2006: spatial, temporal, and demographic patterns

  2007cited by this paper
• Trends of prevalence of primary HIV drug resistance in Germany.

  2007cited by this paper
• Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa

  2007cited by this paper
• Implementation of an Antiretroviral Access Program for HIV-1-Infected Individuals in Resource-Limited Settings: Clinical Results From 4 African Countries

  2007cited by this paper
• Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania.

  2007cited by this paper
• Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review

  2007cited by this paper
• HIV infection presenting in older children and adolescents: a case series from Harare, Zimbabwe.

  2007cited by this paper
• Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.

  2007cited by this paper
• Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.

  2007cited by this paper
• Economic Stress and HIV-Associated Health Care Utilization in a Rural Region of China: A Qualitative Study

  2007cited by this paper
• Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies

  2007cited by this paper
• Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives

  2007cited by this paper
• HIV and tuberculosis coinfection: inextricably linked liaison.

  2007cited by this paper
• Knowledge, Attitudes, And Practices of Antiretroviral Therapy among HIV-Infected Adults Attending Private And Public Clinics in India

  2007cited by this paper
• The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years

  2007cited by this paper
• A Randomized Study of Antiviral Medication Switch at Lower-Versus Higher-Switch Thresholds: AIDS Clinical Trials Group Study A5115

  2007cited by this paper
• Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.

  2007cited by this paper
• Bridging the Gap Between Antiretroviral Access and Adherence in Mexico

  2007cited by this paper
• The Safety and Efficacy of Tenofovir DF in Combination with Lamivudine and Efavirenz Through 6 Years in Antiretroviral-Naïve HIV-1—Infected Patients

  2007cited by this paper
• The Safety and Efficacy of Switching Stavudine to Tenofovir DF in Combination with Lamivudine and Efavirenz in HIV-1—Infected Patients: Three-Year Follow–up After Switching Therapy

  2007cited by this paper
• Adherence to antiretroviral therapy in resource-limited settings: everything matters.

  2007cited by this paper
• Emergence and evolution of drug resistance in the absence of viral load monitoring during 48 weeks of Combivir/Tenofovir within the DART Trial.

  2007cited by this paper
• Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

  2006cited by this paper
• Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy

  2006cited by this paper
• Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

  2006cited by this paper
• Reasons for Modification of Generic Highly Active Antiretroviral Therapeutic Regimens Among Patients in Southern India

  2006cited by this paper
• AIDS Res Hum Retroviruses

  2006cited by this paper
• Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda.

  2006cited by this paper
• Is Moderate HIV Viremia Associated With a Higher Risk of Clinical Progression in HIV-Infected People Treated With Highly Active Antiretroviral Therapy: Evidence From the Italian Cohort of Antiretroviral-Naive Patients Study

  2006cited by this paper
• Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

  2006cited by this paper
• Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.

  2006cited by this paper
• Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya

  2006cited by this paper
• HIV and conflict in Nepal: relation and strategy for response.

  2006cited by this paper
• Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision.

  2006cited by this paper
• Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort

  2006cited by this paper
• Background papers for Working together for health: The World Health Report 2006

  2006cited by this paper
• Rural-to-Urban Migrants and the HIV Epidemic in China

  2006cited by this paper
• Patterns of movement and risk of HIV infection in rural Zimbabwe.

  2005cited by this paper
• Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs

  2005cited by this paper
• The prevalence and risk of immune restoration disease in HIV‐infected patients treated with highly active antiretroviral therapy

  2005cited by this paper
• Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.

  2005cited by this paper
• Antiretroviral therapy in a thousand patients with AIDS in Haiti.

  2005cited by this paper
• Can we estimate the optimum CD4 threshold for starting HAART in antiretroviral-naïve HIV-infected individuals?

  2005cited by this paper
• Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy.

  2004cited by this paper
• Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.

  2004cited by this paper
• Hepatotoxicity associated with nevirapine use.

  2004cited by this paper
• Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia

  2004cited by this paper
• New patterns of HIV-1 resistance during HAART.

  2003cited by this paper
• Drug resistance mutations in HIV-1.

  2003cited by this paper
• Planning STI/HIV prevention among refugees and mobile populations: situation assessment of Sudanese refugees.

  2003cited by this paper
• Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001

  2003cited by this paper
• Drug Resistance Mutations in HIV-1.

  2002cited by this paper
• Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

  2002cited by this paper
• Evolution of Phenotypic Drug Susceptibility and Viral Replication Capacity during Long-Term Virologic Failure of Protease Inhibitor Therapy in Human Immunodeficiency Virus-Infected Adults

  2002cited by this paper
• Structure of HIV-2 reverse transcriptase at 2.35-Å resolution and the mechanism of resistance to non-nucleoside inhibitors

  2002cited by this paper
• Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

  2001cited by this paper
• Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy

  2000cited by this paper
• War, oppression, refugee camps fuel spread of HIV. Migration and HIV.

  1998cited by this paper
• Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000

  1998cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Identifying Effective Child Survival Interventions Child Survival Ii

  year unknowncited by this paper

• Two Decades and Counting Since the Abuja Summit: Where Do We Stand in the Fight Against HIV/AIDS-Related Maternal Mortality?

  2025cites this paper
• Generating Political Priority for the Health Needs of the 21st Century: A Qualitative Policy Analysis on the Prioritization of Rehabilitation Services in Uganda

  2024cites this paper
• Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots: Results from a Pilot Study Among Patients and Providers in Cape Town, South Africa

  2023cites this paper
• Prevalence of depression, syndemic factors and their impact on viral suppression among female sex workers living with HIV in eThekwini, South Africa

  2023cites this paper
• A search for potential anti-HIV phytoconstituents from the natural product repository

  2022cites this paper
• Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation

  2022cites this paper
• Pathways for Dolutegravir Transformation from a Daily Oral to a Once-a-Year Parenteral Medicine

  2022cites this paper
• A Review of Challenges in Performing RT- PCR for COVID-19 in Rural Healthcare Settings

  2021cites this paper
• Incidence and predictors of loss to follow up among adult HIV patients on antiretroviral therapy in University of Gondar Comprehensive Specialized Hospital: A competing risk regression modeling

  2020cites this paper
• Cumplimiento de los indicadores de proceso en un programa para el manejo de pacientes que viven con VIH/SIDA

  2020cites this paper
• RESPONSE ON THE WAY TO FIRST-LINE ANTIRETROVIRAL THERAPY WITHIN HIV PATIENTS

  2019cites this paper
• Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study

  2019cites this paper
• Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens

  2019cites this paper
• A study on local therapy technique that can be used in treatment of AIDS and some other diseases

  2019cites this paper
• Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia

  2018cites this paper
• Health systems flattening – the failed promises of decentralisation in Mozambique

  2018cites this paper
• [Continuum of care of people living with HIV and gaps in achieving the 90-90-90 goals in Peru].

  2018cites this paper
• Diagnosis of Human Immunodeficiency Virus Infection

  2018cites this paper
• Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): A Randomized Controlled Trial

  2018cites this paper
• Treatment outcomes and HIV drug resistance of patients switching to second-line regimens after long-term first-line antiretroviral therapy

  2018cites this paper
• Provision of antiretroviral therapy for children in Nelson Mandela Bay: Health care professionals’ challenges

  2018cites this paper
• Creation of a long-acting nanoformulated dolutegravir

  2018cites this paper
• Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy

  2017cites this paper
• Antiretroviral Adherence Perspectives of Pregnant and Postpartum Women in Guyana

  2017cites this paper
• Assessing factors for loss to follow-up of HIV infected patients in Guinea-Bissau

  2017cites this paper
• Design, synthesis and anti-HIV-1 RT evaluation of 2-(benzyl(4-chlorophenyl)amino)-1-(piperazin-1-yl)ethanone derivatives.

  2017cites this paper
• Etude des résistances du VIH-1 au traitement antirétroviral et amélioration du suivi virologique des patients vivant avec le VIH dans les pays du Sud

  2016cites this paper
• Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia.

  2016cites this paper
• Social determinants of HIV infection among men who have sex with men in the Philippines

  2016cites this paper
• Development of peptide inhibitors of HIV transmission

  2016cites this paper
• Internalized Stigma among HIV-Positive Men on Antiretroviral Therapy in Urban India

  2016cites this paper
• Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART

  2016cites this paper
• HIV-1 variability and viral load technique could lead to false positive HIV-1 detection and to erroneous viral quantification in infected specimens.

  2015cites this paper
• Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations.

  2015cites this paper
• Efficacy of Second-Line Antiretroviral Therapy Among People Living With HIV/AIDS in Asia: Results From the TREAT Asia HIV Observational Database

  2015cites this paper
• Equity in access to HIV/AIDS services in Zambia : the role of social cohesion in HIV prevention and care

  2014cites this paper
• Virological failure among adult HIV positive patients three years after starting antiretroviral treatment at Mankweng Hospital, Limpopo Province, RSA

  2014cites this paper
• Second-line antiretroviral therapy in northern Tanzania

  2014cites this paper
• Impact of Adherence and Anthropometric Characteristics on Nevirapine Pharmacokinetics and Exposure Among HIV-Infected Kenyan Children

  2014cites this paper
• Measuring HIV Associated Mortality in Africa

  2014cites this paper
• Antiretroviral treatment : challenges experienced by HIV positivewomen in Zimbabwe

  2014cites this paper
• Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections.

  2013cites this paper
• HIV treatment in South Africa: the challenges of an increasingly successful antiretroviral programme.

  2013cites this paper
• Antiretroviral Therapy Regimen Change Among HIV / AIDS Patients in Nekemt Hospital : a Primary Care Hospital in Oromia Regional State , Ethiopia

  2013influential citation
• The Impact of Antiretroviral Therapy on the HIV Epidemic in South Africa

  2013cites this paper
• Viral Load Monitoring as a Tool to Reinforce Adherence: A Systematic Review

  2013cites this paper
• Task-Sharing of HIV Care and ART Initiation: Evaluation of a Mixed-Care Non-Physician Provider Model for ART Delivery in Rural Malawi

  2013cites this paper
• Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study

  2013cites this paper
• Developments in virus-like particle-based vaccines for HIV

  2013cites this paper
• [Risk factors associated with virologic failure in HIV- infected patients receiving antiretroviral therapy at a public hospital in Peru].

  2013cites this paper
• Antiretroviral Treatment in Resource-Limited Settings 2012

  2012cites this paper
• Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice

  2012cites this paper
• Four years of experience with antiretroviral therapy in adult patients in Karachi, Sindh, Pakistan.

  2012cites this paper
• Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings

  2012cites this paper
• Challenges and opportunities for the implementation of virological testing in resource-limited settings

  2012cites this paper
• A RIGHTS-BASED APPROACH TO HIV PREVENTION, CARE, SUPPORT AND TREATMENT: A REVIEW OF ITS IMPLEMENTATION IN ETHIOPIA

  2012cites this paper
• Factors influencing adherence to antiretroviral treatment in Asian developing countries: a systematic review

  2012cites this paper
• Prevalence of oral mucosal lesions in adults undergoing highly active antiretroviral therapy in Hong Kong.

  2012cites this paper
• CD4-Specific Mortality Rates Among HIV-Infected Adults With High CD4 Counts and No Antiretroviral Treatment in West Africa

  2012cites this paper
• CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE

  2012cites this paper
• Factors associated with prenatal folic acid and iron supplementation among 21,889 pregnant women in Northern Tanzania: A cross-sectional hospital-based study

  2012cites this paper
• The Impact of the New WHO Antiretroviral Treatment Guidelines on HIV Epidemic Dynamics and Cost in South Africa

  2011cites this paper
• The long road to universal antiretroviral treatment coverage in South Africa

  2011cites this paper
• Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

  2011cites this paper
• The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention.

  2011influential citation
• Mortality and immunovirological outcomes on antiretroviral therapy in HIV-1 and HIV-2-infected individuals in the Gambia

  2011cites this paper
• Morbidity in HIV‐1‐infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population‐based cohort in Uganda

  2011cites this paper
• Rapid Suppression of HIV-RNA Is Associated with Improved Control of Immune Activation in Mozambican Adults Initiating Antiretroviral Therapy with Low CD4 Counts

  2011cites this paper
• Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage

  2011cites this paper
• Health-care worker engagement in HIV-related quality improvement in Dar es Salaam, Tanzania.

  2011cites this paper
• Outcomes of antiretroviral treatment program in Ethiopia: Retention of patients in care is a major challenge and varies across health facilities

  2011influential citation
• The development of a screening tool to evaluate infants who are HIV positive

  2011cites this paper
• A follow-up study of HIV-infected adults in rural Tanzania after antiretroviral treatment failure

  2011cites this paper
• Virologic failure and HIV-1 drug resistance among antiretroviral therapy recipients in an urban resource-limited setting - the South African Virologic Evaluation (SAVE) study

  2011cites this paper
• Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.

  2011cites this paper
• Design Opportunities for Supporting Treatment of People Living with HIV / AIDS in India

  2011cites this paper
• Building a Durable Response to HIV/AIDS: Implications for Health Systems

  2011cites this paper
• Impact of anti-retroviral therapy on the sexual behavior of people living with HIV/AIDS in Addis Ababa, Ethiopia: a qualitative study

  2011cites this paper
• Morbidity and mortality among infants born to HIV-infected women in South Africa: implications for child health in resource-limited settings.

  2011cites this paper
• Analysis of HIV-induced cardiomyopathy using anti-gp120 aptamers

  2011cites this paper
• Genetic Diversity and Drug Resistance Profiles in HIV Type 1- and HIV Type 2-Infected Patients from Cape Verde Islands

  2011cites this paper
• Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders

  2011cites this paper
• Treating HIV in rural South Africa “Successes and Challenges"

  2010cites this paper
• Adjusting Mortality for Loss to Follow-Up: Analysis of Five ART Programmes in Sub-Saharan Africa

  2010cites this paper
• Quality care: a link between clinical and public health approaches to HIV infection in developing countries

  2010cites this paper
• Trends in Retention on Antiretroviral Therapy in National Programs in Low-Income and Middle-Income Countries

  2010influential citation
• Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality

  2010cites this paper
• How HIV treatment could result in effective prevention.

  2010cites this paper
• Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.

  2010cites this paper
• Growth of infants born to HIV‐infected women in South Africa according to maternal and infant characteristics

  2010cites this paper
• Adenovirus specific T-cell responses in humans following natural infection and vaccination

  2010cites this paper
• Adults mortality trends since the introduction of free anti retroviral therapy in the rural hospital of Uganda

  2009cites this paper
• Economic Stress and HIV-Associated Health Care Utilization in a Rural Region of China: A Qualitative Study

  2007cites this paper